Craif's Urine Cancer Test "miSignal Scan" Wins the Communication Contribution Award at the 38th "Hit Product & Trending Product Awards" Hosted by Drug Magazine
NQ Score
81/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Craif's AI-driven urine cancer test "miSignal Scan" won the Communication Contribution Award at the 38th Hit Product Awards, highly evaluated by Japan's drugstore industry.
AI Analysis
Frequently Asked Questions
- Q: What is the MySignal Scan test?
- A: It is a non-invasive test that uses AI to analyze microRNA in urine to evaluate the risk of 10 types of cancer, including pancreatic cancer.
- Q: What award did MySignal win this time?
- A: MySignal won the 'Topic Product Award Communication Contribution Award' at the 38th 'Hit Product Award Topic Product Award'.
- Q: Where was this test kit evaluated?
- A: It was evaluated through voting by leading drugstores and wholesale companies nationwide, organized by Drug Magazine and Yachiyo Association.